BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 10377991)

  • 41. A fumagillin derivative angiogenesis inhibitor, AGM-1470, inhibits activation of cyclin-dependent kinases and phosphorylation of retinoblastoma gene product but not protein tyrosyl phosphorylation or protooncogene expression in vascular endothelial cells.
    Abe J; Zhou W; Takuwa N; Taguchi J; Kurokawa K; Kumada M; Takuwa Y
    Cancer Res; 1994 Jul; 54(13):3407-12. PubMed ID: 8012959
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Apoptotic and mitogenic stimuli inactivate Rb by differential utilization of p38 and cyclin-dependent kinases.
    Nath N; Wang S; Betts V; Knudsen E; Chellappan S
    Oncogene; 2003 Sep; 22(38):5986-94. PubMed ID: 12955077
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Co-purification of p34cdc2/p58cyclin A proline-directed protein kinase and the retinoblastoma tumor susceptibility gene product: interaction of an oncogenic serine/threonine protein kinase with a tumor-suppressor protein.
    Williams RT; Carbonaro-Hall DA; Hall FL
    Oncogene; 1992 Mar; 7(3):423-32. PubMed ID: 1532245
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F.
    Leone G; DeGregori J; Sears R; Jakoi L; Nevins JR
    Nature; 1997 May; 387(6631):422-6. PubMed ID: 9163430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity.
    Khleif SN; DeGregori J; Yee CL; Otterson GA; Kaye FJ; Nevins JR; Howley PM
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4350-4. PubMed ID: 8633069
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).
    Chen WJ; Chang CY; Lin JK
    Biochem Pharmacol; 2003 Jun; 65(11):1777-85. PubMed ID: 12781329
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins.
    Zariwala M; Liu J; Xiong Y
    Oncogene; 1998 Nov; 17(21):2787-98. PubMed ID: 9840943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27.
    Decker T; Schneller F; Hipp S; Miething C; Jahn T; Duyster J; Peschel C
    Leukemia; 2002 Mar; 16(3):327-34. PubMed ID: 11896535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of an alfalfa cyclin-dependent kinase inhibitor by calmodulin-like domain protein kinase.
    Pettkó-Szandtner A; Mészáros T; Horváth GV; Bakó L; Csordás-Tóth E; Blastyák A; Zhiponova M; Miskolczi P; Dudits D
    Plant J; 2006 Apr; 46(1):111-23. PubMed ID: 16553899
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase.
    Lin BT; Gruenwald S; Morla AO; Lee WH; Wang JY
    EMBO J; 1991 Apr; 10(4):857-64. PubMed ID: 2009861
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes.
    Nahum A; Hirsch K; Danilenko M; Watts CK; Prall OW; Levy J; Sharoni Y
    Oncogene; 2001 Jun; 20(26):3428-36. PubMed ID: 11423993
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE; Xiong Y
    Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A cyclin D1/cyclin-dependent kinase 4 binding site within the C domain of the retinoblastoma protein.
    Pan W; Cox S; Hoess RH; Grafström RH
    Cancer Res; 2001 Apr; 61(7):2885-91. PubMed ID: 11306463
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.
    Guan KL; Jenkins CW; Li Y; Nichols MA; Wu X; O'Keefe CL; Matera AG; Xiong Y
    Genes Dev; 1994 Dec; 8(24):2939-52. PubMed ID: 8001816
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phosphorylation of E2F-1 by cyclin A-cdk2.
    Kitagawa M; Higashi H; Suzuki-Takahashi I; Segawa K; Hanks SK; Taya Y; Nishimura S; Okuyama A
    Oncogene; 1995 Jan; 10(2):229-36. PubMed ID: 7838523
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
    Kiess M; Gill RM; Hamel PA
    Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TGF-beta1-induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-cdk 2 activation and retinoblastoma protein phosphorylation.
    Schoecklmann HO; Rupprecht HD; Zauner I; Sterzel RB
    Kidney Int; 1997 Apr; 51(4):1228-36. PubMed ID: 9083291
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Retinoblastoma protein contains a C-terminal motif that targets it for phosphorylation by cyclin-cdk complexes.
    Adams PD; Li X; Sellers WR; Baker KB; Leng X; Harper JW; Taya Y; Kaelin WG
    Mol Cell Biol; 1999 Feb; 19(2):1068-80. PubMed ID: 9891042
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cell cycle-independent induction of D1 and D2 cyclin expression, but not cyclin-Cdk complex formation or Rb phosphorylation, by IFNgamma in macrophages.
    Dey A; Li W
    Biochim Biophys Acta; 2000 Jun; 1497(1):135-47. PubMed ID: 10838167
    [TBL] [Abstract][Full Text] [Related]  

  • 60. G1-checkpoint function including a cyclin-dependent kinase 2 regulatory pathway as potential determinant of 7-hydroxystaurosporine (UCN-01)-induced apoptosis and G1-phase accumulation.
    Akiyama T; Sugiyama K; Shimizu M; Tamaoki T; Akinaga S
    Jpn J Cancer Res; 1999 Dec; 90(12):1364-72. PubMed ID: 10665655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.